Clinical benefit of glycoprotein IIb/IIIa blockade with Abciximab is independent of gender: pooled analysis from EPIC, EPILOG and EPISTENT trials. Evaluation of 7E3 for the Prevention of Ischemic Complications. Evaluation in Percutaneous Transluminal Coronary Angioplasty to Improve Long-Term Outcome with Abciximab GP IIb/IIIa blockade. Evaluation of Platelet IIb/IIIa Inhibitor for Stent. [electronic resource]

By: Contributor(s): Producer: 20000817Description: 381-6 p. digitalISSN:
  • 0735-1097
Subject(s): Online resources: In: Journal of the American College of Cardiology vol. 36
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
No physical items for this record

Publication Type: Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't

There are no comments on this title.

to post a comment.